Myovant Sciences Ltd.
MYOVDelisted Mar 10, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001679082
Myovant Sciences Ltd. was delisted on Mar 10, 2023; its insiders filed their last Form 4 on Mar 10, 2023; 118 institutions reported holding it in 13F filings for Q4 2022, worth $1.12B in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Myovant Sciences Ltd. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 108 | 1 | 105 | −2 |
| Shares | 32.4M | 1.21K | 30.2M | −2.15M (−6.7%) |
| Value | $736.6M | $27.0K | $677.6M | −$59.0M (−8.0%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Myovant Sciences Ltd. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jump Financial, LLC | 93,274 | $2.09M | 0.15% |
| Altshuler Shaham Ltd | 46,219 | $1.04M | 0.01% |
| Two Sigma Investments, LP | 45,136 | $1.01M | 0.00% |
| California State Teachers Retirement System | 29,971 | $673.0K | 0.00% |
| Virginia Retirement Systems Et Al | 21,300 | $478.0K | 0.00% |
| Dynamic Technology Lab Private Ltd | 16,430 | $369.0K | 0.04% |
| Susquehanna Fundamental Investments, LLC | 12,800 | $287.0K | 0.01% |
| Winton Group Ltd | 12,782 | $287.0K | 0.02% |
| Tower Research Capital LLC (TRC) | 10,150 | $228.0K | 0.01% |
| Ergoteles LLC | 9,173 | $206.0K | 0.01% |
| Schonfeld Strategic Advisors LLC | 9,100 | $205.0K | 0.00% |
| Dark Forest Capital Management LP | 1,444 | $32.0K | 0.01% |
| Total Clarity Wealth Management, Inc. | 850 | $19.0K | 0.01% |
| Ironwood Financial, llc | 315 | $7.00K | 0.00% |
Sold out (16)
Institutions that held Myovant Sciences Ltd. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| PFM Health Sciences, LP | 1,912,188 | $43.5M |
| Schroder Investment Management Group | 246,528 | $5.61M |
| Marshall Wace North America L.P. | 192,994 | $4.39M |
| Point72 Asset Management, L.P. | 154,800 | $3.52M |
| Raymond James & Associates | 75,086 | $1.71M |
| Arrowstreet Capital, Limited Partnership | 69,800 | $1.59M |
| Nuveen Asset Management, LLC | 65,856 | $1.50M |
| Marshall Wace, LLP | 25,814 | $588.0K |
| Invesco Ltd. | 23,690 | $540.0K |
| Engineers Gate Manager LP | 20,270 | $462.0K |
| Trexquant Investment LP | 17,466 | $398.0K |
| Verition Fund Management LLC | 15,241 | $347.0K |
| Pinz Capital Management, LP | 5,500 | $125.0K |
| Advisory Services Network, LLC | 2,650 | $60.0K |
| Lindbrook Capital, LLC | 1,000 | $23.0K |
| Community Bank, N.A. | 500 | $11.0K |
Not filed for Q3 2021 yet (1)
Institutions that held Myovant Sciences Ltd. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| CWM, LLC | 1,205 | $27.0K |